Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Elisabetta, Garibaldi"'
Autor:
Nuradh Joseph, Alessandro Cicchetti, Alan McWilliam, Adam Webb, Petra Seibold, Claudio Fiorino, Cesare Cozzarini, Liv Veldeman, Renée Bultijnck, Valérie Fonteyne, Christopher J. Talbot, Paul R. Symonds, Kerstie Johnson, Tim Rattay, Maarten Lambrecht, Karin Haustermans, Gert De Meerleer, Rebecca M. Elliott, Elena Sperk, Carsten Herskind, Marlon Veldwijk, Barbara Avuzzi, Tommaso Giandini, Riccardo Valdagni, David Azria, Marie-Pierre Farcy Jacquet, Marie Charissoux, Ana Vega, Miguel E. Aguado-Barrera, Antonio Gómez-Caamaño, Pierfrancesco Franco, Elisabetta Garibaldi, Giuseppe Girelli, Cinzia Iotti, Vittotorio Vavassori, Jenny Chang-Claude, Catharine M. L. West, Tiziana Rancati, Ananya Choudhury
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionWe hypothesized that increasing the pelvic integral dose (ID) and a higher dose per fraction correlate with worsening fatigue and functional outcomes in localized prostate cancer (PCa) patients treated with external beam radiotherapy (EBR
Externí odkaz:
https://doaj.org/article/f2bb34992a8046558fc9d3a6f82986a3
Autor:
Igor Monsellato, Elisabetta Garibaldi, Elisa Cassinotti, Ludovica Baldari, Luigi Boni, Ugo Elmore, Roberto Delpini, Riccardo Rosati, Roberto Perinotti, Filippo Alongi, Elisa Bertocchi, Stefania Gori, Giacomo Ruffo, Graziano Pernazza, Fabio Pulighe, Carlo De Nisco, Emilio Morpurgo, Tania Contardo, Enzo Mammano, Federico Perna, Benedetta Menegatti, Andrea Coratti, Piero Buccianti, Riccardo Balestri, Cristina Ceccarelli, Davide Cavaliere, Leonardo Solaini, Giorgio Ercolani, Elena Traverso, Vittorio Fusco, Valter Torri, Sara Orecchia
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-7 (2020)
Abstract Background Neoadjuvant chemoradiotherapy followed by surgery is the mainstay treatment for locally advanced rectal cancer, leading to significant decrease in tumor size (downsizing) and a shift towards earlier disease stage (downstaging). Ex
Externí odkaz:
https://doaj.org/article/0795aa4e705041fe835f6a6efbd83c87
Autor:
Xiaodong Zhuang, Federica Maione, Joseph Robinson, Michael Bentley, Baksho Kaul, Katharine Whitworth, Neeraj Jumbu, Elizabeth Jinks, Jonas Bystrom, Pietro Gabriele, Elisabetta Garibaldi, Elena Delmastro, Zsuzsanna Nagy, David Gilham, Enrico Giraudo, Roy Bicknell, Steven P. Lee
Publikováno v:
JCI Insight, Vol 5, Iss 19 (2020)
Engineering T cells to express chimeric antigen receptors (CARs) specific for antigens on hematological cancers has yielded remarkable clinical responses, but with solid tumors, benefit has been more limited. This may reflect lack of suitable target
Externí odkaz:
https://doaj.org/article/078810883ce8406690b91f1dcd2ace3b
Autor:
Tim Rattay, Petra Seibold, Miguel E. Aguado-Barrera, Manuel Altabas, David Azria, Gillian C. Barnett, Renée Bultijnck, Jenny Chang-Claude, Ananya Choudhury, Charlotte E. Coles, Alison M. Dunning, Rebecca M. Elliott, Marie-Pierre Farcy Jacquet, Sara Gutiérrez-Enríquez, Kerstie Johnson, Anusha Müller, Giselle Post, Tiziana Rancati, Victoria Reyes, Barry S. Rosenstein, Dirk De Ruysscher, Maria C. de Santis, Elena Sperk, Hilary Stobart, R. Paul Symonds, Begoña Taboada-Valladares, Ana Vega, Liv Veldeman, Adam J. Webb, Catharine M. West, Riccardo Valdagni, Christopher J. Talbot, REQUITE consortium, Yolande Lievens, Marc van Eijkeren, Piet Ost, Valérie Fonteyne, Christel Monten, Wilfried De Neve, Stephanie Peeters, Karin Haustermans, Caroline Weltens, Gilles Defraene, Maarten Lambrecht, Erik van Limberghen, Erik Briers, Celine Bourgier, Muriel Brengues, Roxana Draghici, Francoise Bons, Thomas Blaschke, Christian Weiß, Irmgard Helmbold, Christian Weißenberger, Petra Stegmaier, Johannes Claßen, Ulrich Giesche, Marie-Luise Sautter-Bihl, Burkhard Neu, Thomas Schnabel, Michael Ehmann, Benjamin Gauter-Fleckenstein, Carsten Herskind, Marlon Veldwijk, Jörg Schäfer, Tommaso Giandini, Marzia Franceschini, Claudia Sangalli, Barbara Avuzzi, Sara Morlino, Laura Lozza, Gabriele Pietro, Elena Delmastro, Elisabetta Garibaldi, Alessandro Cicchetti, Ben Vanneste, Bibiana Piqué-Leiva, Meritxel Molla, Alexandra Giraldo, Monica Ramos, Ramon Lobato-Busto, Paloma Sosa-Fajardo, Laura Torrado Moya, Isabel Dominguez-Rios, Irene Fajardo-Paneque, Patricia Calvo-Crespo, Ana Carballo, Paula Peleteiro, Olivia-Fuentes-Rios, Antonio Gomez-Caamano, Victoria Harrop, Debbie Payne, Manjusha Keni, Samuel Lavers, Simon Wright, Sridhar Thiagarajan, Luis Aznar-Garcia, Kiran Kancherla, Christopher Kent, Subramaniam Vasanthan, Donna Appleton, Monika Kaushik, Frances Kenny, Hazem Khout, Jaroslaw Krupa, Kelly V. Lambert, Simon Pilgrim, Sheila Shokuhi, Kalliope Valassiadou, Ion Bioangiu, Kufre Sampson, Ahmed Osman, Corinne Faivre-Finn, Karen Foweraker, Abigail Pascoe, Claire P. Esler, Tim Ward, Daniel S. Higginson, Richard G. Stock, Sheryl Green
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Acute skin toxicity is a common and usually transient side-effect of breast radiotherapy although, if sufficiently severe, it can affect breast cosmesis, aftercare costs and the patient's quality-of-life. The aim of this study was to deve
Externí odkaz:
https://doaj.org/article/8c6dd513848e4d99a2a71215a83b3a38
Autor:
Andrea Bresolin, Elisabetta Garibaldi, Adriana Faiella, Domenico Cante, Vittorio Vavassori, Justina Magdalena Waskiewicz, Giuseppe Girelli, Barbara Avuzzi, Elisa Villa, Alessandro Magli, Barbara Noris Chiorda, Fernando Munoz, Giuseppe Sanguineti, Pietro Gabriele, Marco Gatti, Tiziana Rancati, Riccardo Valdagni, Nadia Di Muzio, Claudio Fiorino, Cesare Cozzarini
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Objective: To investigate predictors of patient-reported urinary incontinence (PRUI) in the first 2 years after post-prostatectomy radiotherapy (PORT) with particular emphasis on possible dose-effect relationships.Patients and Methods: Two-hundred-th
Externí odkaz:
https://doaj.org/article/ed4ce5d7d891471a857970e84b0d0dcd
Autor:
Fernando Munoz, Giuseppe Sanguineti, Andrea Bresolin, Domenico Cante, Vittorio Vavassori, Justina Magdalena Waskiewicz, Giuseppe Girelli, Barbara Avuzzi, Elisabetta Garibaldi, Adriana Faiella, Elisa Villa, Alessandro Magli, Barbara Noris Chiorda, Marco Gatti, Tiziana Rancati, Riccardo Valdagni, Nadia G. Di Muzio, Claudio Fiorino, Cesare Cozzarini
Publikováno v:
Cancers, Vol 13, Iss 13, p 3243 (2021)
Background: Baseline urinary incontinence (UI) strongly modulates UI recovery after adjuvant/salvage radiotherapy (ART/SRT), inducing clinicians to postpone it “as much as possible”, maximizing UI recovery but possibly reducing efficacy. This ser
Externí odkaz:
https://doaj.org/article/04854987dacb4f8aad8c092195eaf46c
Autor:
Cesare Cozzarini, Michela Olivieri, Alessandro Magli, Domenico Cante, Barbara Noris Chiorda, Fernando Munoz, Adriana Faiella, Elisa Olivetta, Chiara Deantoni, Andrei Fodor, Marco Andrea Signor, Edoardo Petrucci, Barbara Avuzzi, Letizia Ferella, Alice Pastorino, Elisabetta Garibaldi, Marco Gatti, Luciana Rago, Teodora Statuto, Tiziana Rancati, Alberto Briganti, Francesco Montorsi, Riccardo Valdagni, Giuseppe Sanguineti, Nadia Gisella Di Muzio, Claudio Fiorino
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 175
Explainable models of long-term risk of biochemical failure (BF) after post-prostatectomy salvage radiotherapy (SRT) are lacking. A previously introduced radiobiology-based formula was adapted to incorporate the impact of pelvic nodes irradiation (PN
Autor:
A. Bresolin, Elisabetta Garibaldi, E. Olivetta, Alessandro Magli, A. Faiella, Cristina Piva, P. Ferrari, Fabio Badenchini, Marco Gatti, N. Di Muzio, Giuseppe Sanguineti, Tiziana Rancati, Eugenio Villa, Barbara Avuzzi, Domenico Cante, Fernando Munoz, L. Ferella, Giuseppe Girelli, V. Vavassori, Claudio Fiorino, Cesare Cozzarini, J.M. Waskiewicz, Riccardo Valdagni, E. Moretti, B. Noris Chiorda
Publikováno v:
Radiotherapy and Oncology. 161:S1101-S1103
Autor:
A. Webb, David Azria, Sarah L. Kerns, Karen Foweraker, Ana Carballo, Barbara Avuzzi, Luis Aznar-Garcia, Roxana Draghici, Monica Ramos, Stéphanie Peeters, Benjamin Gauter-Fleckenstein, Daniel S. Higginson, Anna Maria Paganoni, Ulrich Giesche, Monika Kaushik, Corinne Faivre-Finn, Ananya Choudhury, Andrea Manzoni, Jörg Schäfer, Carsten Herskind, Frances Kenny, Paolo Zunino, Valérie Fonteyne, Abigail Pascoe, S. Morlino, Paloma Sosa-Fajardo, Manjusha Keni, Karin Haustermans, A. Giraldo, Jaroslaw Krupa, Claudia Sangalli, Thomas Schnabel, Gert De Meerleer, Yolande Lievens, Patricia Calvo-Crespo, Marie-Pierre Farcy-Jacquet, Petra Seibold, Nicola Rares Franco, Ramón Lobato-Busto, Irene Fajardo-Paneque, Tim Rattay, Ana Vega, Riccardo Valdagni, Elena Delmastro, Irmgard Helmbold, Ben G. L. Vanneste, Richard G. Stock, Donna Appleton, Debbie Payne, Barry S. Rosenstein, Liv Veldeman, Rebecca Elliott, Tiziana Rancati, Alison M. Dunning, Claire P. Esler, Sridhar Thiagarajan, Elisabetta Garibaldi, Muriel Brengues, Michela Carlotta Massi, Simon Pilgrim, Maria C. De Santis, Wilfried De Neve, Miguel E. Aguado-Barrera, Evert J. Van Limbergen, Olivia-Fuentes-Rios, Paul Symonds, Jenny Chang-Claude, Elena Sperk, Catharine M L West, Petra Stegmaier, Antonio Gómez-Caamaño, Marzia Franceschini, Laura Torrado Moya, Simon Wright, Kufre Sampson, Kalliope Valassiadou, Francesca Ieva, Burkhard Neu, Isabel Dominguez-Rios, Francoise Bons, Marie-Luise Sautter-Bihl, Gilles Defraene, Tommaso Giandini, Meritxel Molla, Sheryl Green, Victoria Harrop, Alessandro Cicchetti, Christian Weiß, Caroline Weltens, Gabriele Pietro, Christopher Kent, Michael Ehmann, Paula Peleteiro, Dirk De Ruysscher, Thomas Blaschke, Ion Bioangiu, Hazem Khout, Samuel Lavers, Ahmed Osman, Laura Fachal, Subramaniam Vasanthan, Marc van Eijkeren, Laura Lozza, Céline Bourgier, Kelly Lambert, Johannes Claßen, Piet Ost, Kerstie Johnson, Christian Weißenberger, Bibiana Piqué-Leiva, Timothy H Ward, Christel Monten, Maarten Lambrecht, Marlon R. Veldwijk, Erik van Limberghen, Kiran Kancherla, Christopher J. Talbot, Barbara Noris Chiorda, Erik Briers, Sheila Shokuhi
Publikováno v:
RADIOTHERAPY AND ONCOLOGY
Radiotherapy and Oncology, 159, 241-248. Elsevier Ireland Ltd
Radiotherapy and Oncology, 159, 241-248. Elsevier Ireland Ltd
AIM: To identify the effect of single nucleotide polymorphism (SNP) interactions on the risk of toxicity following radiotherapy (RT) for prostate cancer (PCa) and propose a new method for polygenic risk score incorporating SNP-SNP interactions (PRSi)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41a7b893793cb9be0c1758ad6b546648
https://lirias.kuleuven.be/handle/20.500.12942/691375
https://lirias.kuleuven.be/handle/20.500.12942/691375
Autor:
Marco Gatti, A. Faiella, Alessandro Magli, Barbara Avuzzi, Riccardo Valdagni, Nadia Di Muzio, Fernando Munoz, J.M. Waskiewicz, Claudio Fiorino, Giuseppe Girelli, Elisa Villa, Domenico Cante, Cesare Cozzarini, Vittorio Vavassori, A. Bresolin, Tiziana Rancati, Barbara Noris Chiorda, Elisabetta Garibaldi, Giuseppe Sanguineti
Publikováno v:
Cancers
Cancers, Vol 13, Iss 3243, p 3243 (2021)
Volume 13
Issue 13
Cancers, Vol 13, Iss 3243, p 3243 (2021)
Volume 13
Issue 13
Background: Baseline urinary incontinence (UI) strongly modulates UI recovery after adjuvant/salvage radiotherapy (ART/SRT), inducing clinicians to postpone it “as much as possible”, maximizing UI recovery but possibly reducing efficacy. This ser